Pulmonary Embolism (PE), Pulmonary Thromboembolism
Conditions
Brief summary
A study based on a chart review of participants that presented with a sudden blood clot in the lung
Interventions
OTHERNon-Interventional
Non-Interventional
Sponsors
Bristol-Myers Squibb
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults participants at date of admission * Primary presentation consistent with PE followed by objectively-confirmed acute PE * Received anti-coagulation upon diagnosis of PE during study period and in receipt of anti-coagulation at discharge
Exclusion criteria
* PE diagnosed during a hospital admission for a reason other than PE during the study period * Patients receiving anticoagulation at the time of presentation * Patients presenting outside the defined study period Other protocol defined inclusion/
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the average length of stay in secondary care | 60 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total length of stay, including repeat admissions | During the first 30 days after presentation of PE | — |
| Distribution of clinical characteristics of patients admitted with a PE | Baseline | Clinical characteristics will be summarized using descriptive statistics |
| Distribution of demographic data of patients admitted with a PE | Baseline | Demographic data will be summarized using descriptive statistics |
Countries
United Kingdom
Outcome results
None listed